{"text": "$mrk any big pharma companys that is in the cancer business want \na peace of keytruda ."}
{"text": "$mrk  glad to see sec filling on compinsation practis ! great stuff ."}
{"text": "#keytruda is now approved in combination with inlyta (axitinib), a tyrosine kinase inhibitor, for the first-line treatment of patients with advanced renal cell carcinoma (rcc) based on findings from the pivotal phase 3 keynote-426 trial vs. sutent $mrk  URL"}
